Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Copple

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?Ian M Copple
Molecular Therapy. Nucleic Acids|January 26, 2023
Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancerGeorgina L Gregory, Ian M Copple
Trends in Pharmacological Sciences|January 11, 2023
Advances and challenges in therapeutic targeting of NRF2Albena T Dinkova-Kostova, Ian M Copple
Redox Biology|April 1, 2026
Sex-based differences in the NRF2 oxidative stress response: Implications for precision therapeuticsGiusy Russomanno, Karolina Kwiatkowska, Ian M Copple
Toxicology and Applied Pharmacology|September 1, 1992
Effects of methapyrilene measured in mitochondria isolated from naive and methapyrilene-treated rat and mouse hepatocytesD M Copple, G F Rush, F C Richardson
Carcinogenesis|December 1, 1992
Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposureF C Richardson, D M Copple, P I Eacho
Biochemical Society Transactions|November 10, 2015
Value of monitoring Nrf2 activity for the detection of chemical and oxidative stressFiona E Mutter, B Kevin Park, Ian M Copple
Kidney International|June 21, 2013
Role of Nrf2 in protection against acute kidney injuryLuke M Shelton, B Kevin Park, Ian M Copple
Multiple Sclerosis and Related Disorders|March 10, 2019
SFX-01 reduces residual disability after experimental autoimmune encephalomyelitisIan Galea, Ian M Copple, David W Howat, et al.
Plos Biology|June 17, 2009
Allometry of the duration of flight feather molt in birdsSievert Rohwer, Robert E Ricklefs, Vanya G Rohwer, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
The Keap1-Nrf2 cell defense pathway--a promising therapeutic target?Ian M Copple
Molecular Therapy. Nucleic Acids|January 26, 2023
Modulating the expression of tumor suppressor genes using activating oligonucleotide technologies as a therapeutic approach in cancerGeorgina L Gregory, Ian M Copple
Trends in Pharmacological Sciences|January 11, 2023
Advances and challenges in therapeutic targeting of NRF2Albena T Dinkova-Kostova, Ian M Copple
Redox Biology|April 1, 2026
Sex-based differences in the NRF2 oxidative stress response: Implications for precision therapeuticsGiusy Russomanno, Karolina Kwiatkowska, Ian M Copple
Toxicology and Applied Pharmacology|September 1, 1992
Effects of methapyrilene measured in mitochondria isolated from naive and methapyrilene-treated rat and mouse hepatocytesD M Copple, G F Rush, F C Richardson
Carcinogenesis|December 1, 1992
Effects of methapyrilene on DNA synthesis in mice and rats following continuous dietary exposureF C Richardson, D M Copple, P I Eacho
Biochemical Society Transactions|November 10, 2015
Value of monitoring Nrf2 activity for the detection of chemical and oxidative stressFiona E Mutter, B Kevin Park, Ian M Copple
Kidney International|June 21, 2013
Role of Nrf2 in protection against acute kidney injuryLuke M Shelton, B Kevin Park, Ian M Copple
Multiple Sclerosis and Related Disorders|March 10, 2019
SFX-01 reduces residual disability after experimental autoimmune encephalomyelitisIan Galea, Ian M Copple, David W Howat, et al.
Plos Biology|June 17, 2009
Allometry of the duration of flight feather molt in birdsSievert Rohwer, Robert E Ricklefs, Vanya G Rohwer, et al.
Pageof 5